Technical Analysis for RZLT - Rezolute Inc.

Grade Last Price % Change Price Change
grade D 0.14 -6.54% -0.0098
RZLT closed down 6.54 percent on Tuesday, January 21, 2020, on 2.54 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical RZLT trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Weak + Overbought Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
20 DMA Support Bullish -6.54%
Crossed Above 50 DMA Bullish -6.54%
Older signals for RZLT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Rezolute, Inc., a clinical stage biopharmaceutical company, specializes in the development of drug therapies for the treatment of patients with metabolic and orphan diseases in the United States. Its products include RZ358, a human monoclonal antibody that is in Phase II clinical trial for the treatment of congenital hyperinsulinism, a devastating ultra-orphan pediatric disease; RZ402, a plasma kallikrein inhibitor, which is in late stage preclinical program for the treatment of diabetic macular edema; and RZ602, a product candidate that is in preclinical trial for the treatment of hereditary angioedema. It also develops AB101, a human recombinant insulin, which is in Phase I clinical trial for the treatment of patients with type 1 and type 2 diabetes mellitus. Rezolute, Inc. has a development and license agreement with ActiveSite Pharmaceuticals, Inc. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Louisville, Colorado.
Medicine RTT Clinical Medicine Organ Systems Monoclonal Antibodies Stage Biopharmaceutical Diabetic Retinopathy Diabetes Mellitus Diabetic Macular Edema Macular Edema Drug Therapies Hereditary Angioedema Complement Deficiency Anti–Vascular Endothelial Growth Factor Therapy Congenital Hyperinsulinism

Is RZLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.496
52 Week Low 0.08
Average Volume 35,085
200-Day Moving Average 0.1813
50-Day Moving Average 0.1390
20-Day Moving Average 0.1291
10-Day Moving Average 0.1386
Average True Range 0.0178
ADX 20.18
+DI 25.0302
-DI 17.2108
Chandelier Exit (Long, 3 ATRs ) 0.1066
Chandelier Exit (Short, 3 ATRs ) 0.1369
Upper Bollinger Band 0.1588
Lower Bollinger Band 0.0994
Percent B (%b) 0.68
BandWidth 46.0108
MACD Line 0.0002
MACD Signal Line -0.0019
MACD Histogram 0.0021
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1520
Resistance 3 (R3) 0.1533 0.1507 0.1500
Resistance 2 (R2) 0.1507 0.1476 0.1500 0.1493
Resistance 1 (R1) 0.1453 0.1457 0.1440 0.1440 0.1487
Pivot Point 0.1427 0.1427 0.1420 0.1420 0.1427
Support 1 (S1) 0.1373 0.1396 0.1360 0.1360 0.1313
Support 2 (S2) 0.1347 0.1377 0.1340 0.1307
Support 3 (S3) 0.1293 0.1347 0.1300
Support 4 (S4) 0.1280